SEC Form 4 · accession 0001104659-17-071933
Amphastar Pharmaceuticals, Inc. · AMPH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
William J Peters
Officer — CFO, SVP & Treasurer
Period of report
Dec 1, 2017
Accepted (ET)
Dec 5, 2017 · 4:30 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001297184
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Dec 1, 2017 | S | 6,226 | $19.67 | D | 78,314 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 13, 2017.
- F2Includes an aggregate of 1,044 shares acquired under the Issuer's 2014 Employee Stock Purchase Plan on May 31, 2017 and November 30, 2017.
Remarks
Exhibit 24 - Power of Attorney